PA

Pallavi Atul Godghate

Active Director Director DIN 09664216
DIN 09664216 First appointment Jul 2022
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pallavi Atul Godghate

Data last updated:

Pallavi Atul Godghate is a Director at Jivak Medical Private Limited (since 2022).

DIN 09664216
Primary Designation Director
First Appointment 07 Jul 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jivak Medical Private Limited U86100MH2021PTC359462
Director07 Jul 20222021Active

Directorship timeline

Open interactive timeline →
Jivak Medical Private Limited
Premium access

Shareholding and investment profile for Pallavi Atul Godghate

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Atul Godghate

Pallavi Atul Godghate currently holds 1 directorship: Jivak Medical Private Limited (Director, since 07 Jul 2022).

Pallavi Atul Godghate was first appointed on 07 Jul 2022 as Director at Jivak Medical Private Limited.

The current boards of Pallavi Atul Godghate's companies include Jayshree Kunal Patil (Jivak Medical Private Limited), Kshama Nitin Shende (Jivak Medical Private Limited), Narendra Damodar Patil (Jivak Medical Private Limited), Prafulla Sakhare (Jivak Medical Private Limited), Sanjay Ganpat Ramteke (Jivak Medical Private Limited), Sanjay Shamrao Wane (Jivak Medical Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available